Salipro Biotech Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$830K
- Investors
-
5
Salipro Biotech General Information
Description
Developer of a biotechnology platform designed to assist researchers in working with membrane proteins in a stabilized lipid environment. The company isolates membrane proteins from the cells of the body so that they retain their stability and activity, enabling researchers to develop therapeutic antibodies, small molecules targeting membrane proteins and drug discovery for a wide range of diseases.
Contact Information
Website
www.salipro.comCorporate Office
- Teknikringen 38A
- 114 28 Stockholm
- Sweden
Corporate Office
- Teknikringen 38A
- 114 28 Stockholm
- Sweden
Salipro Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 11-Mar-2020 | $830K | Completed | Generating Revenue | ||
| 5. Grant | 01-Dec-2019 | Completed | Generating Revenue | |||
| 4. Seed Round | 18-Jan-2016 | Completed | Generating Revenue | |||
| 3. Grant | 11-Jan-2016 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2014 | $7.19K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Salipro Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
Salipro Biotech Patents
Salipro Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4123307-A1 | Methods for structure determination and drug design using salipro particles | Inactive | 22-Jul-2021 | ||
| WO-2023001912-A1 | Methods for structure determination and drug design using salipro particles | Inactive | 22-Jul-2021 | ||
| JP-2022529132-A | Manufacture of saripro particles | Active | 15-Apr-2019 | ||
| AU-2020257991-A1 | Production of salipro particles | Active | 15-Apr-2019 | ||
| AU-2020257991-B2 | Production of salipro particles | Active | 15-Apr-2019 | A61K9/1275 |
Salipro Biotech Signals
Salipro Biotech Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Wingefors Invest | Venture Capital | Minority | ||
| Vinnova | Government | |||
| Uppsala Innovation Centre | Accelerator/Incubator |
Salipro Biotech FAQs
-
When was Salipro Biotech founded?
Salipro Biotech was founded in 2013.
-
Where is Salipro Biotech headquartered?
Salipro Biotech is headquartered in Stockholm, Sweden.
-
What is the size of Salipro Biotech?
Salipro Biotech has 10 total employees.
-
What industry is Salipro Biotech in?
Salipro Biotech’s primary industry is Drug Discovery.
-
Is Salipro Biotech a private or public company?
Salipro Biotech is a Private company.
-
What is the current valuation of Salipro Biotech?
The current valuation of Salipro Biotech is .
-
What is Salipro Biotech’s current revenue?
The current revenue for Salipro Biotech is .
-
How much funding has Salipro Biotech raised over time?
Salipro Biotech has raised $1.07M.
-
Who are Salipro Biotech’s investors?
, , Wingefors Invest, Vinnova, and Uppsala Innovation Centre have invested in Salipro Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process